Dramamine Less Drowsy Tablet
NDC Package 63029-903-01
Package Information
Dramamine Less Drowsy (meclizine hydrochloride) tablets is take first dose one hour before starting activityadults and children 12 years and over: 1 to 2 tablets once daily, or as directed by a doctor. This formulation utilizes a tablet delivery system. Marketed by Medtech Products Inc., this product is identified by NDC 63029-903 and is authorized under FDA application M009.
Identification & Billing
- RxCUI: 995666 - meclizine HCl 25 MG Oral Tablet
- RxCUI: 995666 - meclizine hydrochloride 25 MG Oral Tablet
- RxCUI: 995726 - Dramamine Less Drowsy 25 MG Oral Tablet
- RxCUI: 995726 - meclizine hydrochloride 25 MG Oral Tablet [Dramamine Less Drowsy]
- RxCUI: 995726 - Dramamine II 25 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 63029 - Medtech Products Inc.
- 63029-903 - Dramamine Less Drowsy
- 63029-903-01 - 1 BOTTLE in 1 BLISTER PACK / 8 TABLET in 1 BOTTLE
- 63029-903 - Dramamine Less Drowsy
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (63029-903). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 63029-903-01 identifies a specific commercial package of 1 bottle in 1 blister pack / 8 tablet in 1 bottle of Dramamine Less Drowsy, a human over the counter drug labeled by Medtech Products Inc.. This tablet is formulated for oral use and contains meclizine dihydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Medtech Products Inc. on September 01, 2011. The current certification is valid through December 31, 2027.
How is this Medtech Products Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 63029090301. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.